MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, M. E.
Right arrow Articles by Bean, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, M. E.
Right arrow Articles by Bean, B. P.

Structure and properties of omega-agatoxin IVB, a new antagonist of P- type calcium channels

ME Adams, IM Mintz, MD Reily, V Thanabal and BP Bean

Department of Entomology, University of California, Riverside 92521.

A new peptide antagonist of voltage-activated calcium channels was purified from venom of the funnel web spider, Agelenopsis aperta. This 48-amino acid peptide, omega-agatoxin (omega-Aga)-IVB, was found to be a potent (Kd, approximately 3 nM) blocker of P-type calcium channels in rat cerebellar Purkinje neurons but had no activity against T-type, L- type, or N-type calcium channels in a variety of neurons. The calcium channel-blocking properties of omega-Aga-IVB were similar to those of another toxin, omega-Aga-IVA, which has 71% amino acid identity with omega-Aga-IVB. The 10-fold greater abundance of omega-Aga-IVB in venom allowed structural studies using NMR spectroscopy. The three- dimensional structure derived from NMR data resulted in a proposed disulfide bond configuration for the peptide. Although omega-Aga-IVB has fewer basic and more acidic residues than does omega-Aga-IVA, the two toxins show conservation of positively charged residues in a mid- peptide region that is predicted to form one face of the omega-Aga-IVB molecule. This region may be crucial for high affinity binding to the P- type calcium channel. In contrast, the amino termini of the two toxins have different charges and seem unlikely to be involved in binding to the channel.

Volume 44, Issue 4, pp. 681-688, 10/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
H. W. Tedford and G. W. Zamponi
Direct G Protein Modulation of Cav2 Calcium Channels
Pharmacol. Rev., December 1, 2006; 58(4): 837 - 862.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
P. Escoubas, C. Bernard, G. Lambeau, M. Lazdunski, and H. Darbon
Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels
Protein Sci., July 1, 2003; 12(7): 1332 - 1343.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. B. Bergsman and R. W. Tsien
Syntaxin Modulation of Calcium Channels in Cortical Synaptosomes As Revealed by Botulinum Toxin C1
J. Neurosci., June 15, 2000; 20(12): 4368 - 4378.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jun, E. S. Piedras-Renteria, S. M. Smith, D. B. Wheeler, S. B. Lee, T. G. Lee, H. Chin, M. E. Adams, R. H. Scheller, R. W. Tsien, et al.
Ablation of P/Q-type Ca2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha 1A-subunit
PNAS, December 21, 1999; 96(26): 15245 - 15250.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. G. Sutton, C. Siok, A. Stea, G. W. Zamponi, S. D. Heck, R. A. Volkmann, M. K. Ahlijanian, and T. P. Snutch
Inhibition of Neuronal Calcium Channels by a Novel Peptide Spider Toxin, DW13.3
Mol. Pharmacol., August 1, 1998; 54(2): 407 - 418.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Yan and M. E. Adams
Lycotoxins, Antimicrobial Peptides from Venom of the Wolf Spider Lycosa carolinensis
J. Biol. Chem., January 23, 1998; 273(4): 2059 - 2066.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. I. McDonough, R. A. Lampe, R. A. Keith, and B. P. Bean
Voltage-Dependent Inhibition of N- and P-Type Calcium Channels by the Peptide Toxin omega -Grammotoxin-SIA
Mol. Pharmacol., December 1, 1997; 52(6): 1095 - 1104.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Shikata, T. Watanabe, T. Teramoto, A. Inoue, Y. Kawakami, Y. Nishizawa, K. Katayama, and M. Kuwada
Isolation and Characterization of a Peptide Isomerase from Funnel Web Spider Venom
J. Biol. Chem., July 14, 1995; 270(28): 16719 - 16723.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Heck, C. Siok, K. Krapcho, P. Kelbaugh, P. Thadeio, M. Welch, R. Williams, A. Ganong, M. Kelly, A. Lanzetti, et al.
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin
Science, November 11, 1994; 266(5187): 1065 - 1068.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics